^
193K Pfizer jabs from COVAX facility to reach Philippines on May 10 â Duque
Health Secretary Francisco Duque III, National Task Force Against COVID-19 Chief Secretary Carlito Galvez, Jr., and other stakeholders are joined by US Embassy representatives to welcome the arrival of two million additional doses of AstraZeneca's COVID- 19 vaccine on May 8, 2021.
US Embassy in the Philippines/Released

193K Pfizer jabs from COVAX facility to reach Philippines on May 10 — Duque

(Philstar.com) - May 8, 2021 - 5:20pm

MANILA, Philippines — A shipment of 193,000 coronavirus vaccines developed by American drugmaker Pfizer is expected to arrive in the Philippines on Monday, Health Secretary Francisco Duque III confirmed. 

The health secretary said this during a press conference held Saturday following the arrival of 2 million AstraZeneca vaccines, also from the World Health Organization-led COVAX facility. 

Vaccine czar Carlito Galvez Jr. previously said shots from Pfizer jabs will likely be distributed to Metro Manila, Davao and Cebu — areas that have the capacity to store them at the required temperature of -70°C. The standard temperature within the existing cold chain system in the country is about 2°C to 8°C. 

The Pfizer vaccines arriving on Monday will be the country's first batch of jabs from the American drugmaker. The delivery will also bring the total number of vaccines shipped to the Philippines to about 7.69 million.

A little more than 421,000 people have been fully vaccinated against COVID-19 since the government kicked off its inoculation program in March. Over 1.8 million Filipinos have received their first dose. 

— Bella Perez-Rubio with reports from Xave Gregorio and The STAR 

COVID-19 NOVEL CORONAVIRUS
Philstar
  • Latest
  • Trending
Latest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

FORGOT PASSWORD?
SIGN IN
or sign in with